Financial Strategy
Strategic Sale vs. MBO: The Math Before You Sign the LOI
For a DTC brand under $10M EBITDA, a management buyout usually bids 15-30% below a strategic sale because it has no cost savings to underwrite. At $5M EBITDA the day-one cash gap can top $5M, widened further by the seller note an MBO almost always requires.
Key Takeaways
- A financial buyer (MBO team, PE add-on) usually bids 15-30% below a strategic acquirer for the same DTC brand, because they have no cost-savings budget to underwrite. That is roughly 1-2 turns of EBITDA.
- At $5M EBITDA, the day-one cash gap can exceed $5M. A strategic sale at 5.5x pays $27.5M all cash. An MBO at 5x with a 15% seller note pays about $21.3M in hand at closing.
- MBO deals almost always require a seller note. Seller notes in lower middle market deals typically run 10-15% of purchase price, and the trend has tightened as senior lending has contracted. In an MBO you are lending the buyer part of your own price.
- If the MBO uses an SBA 7(a) loan, your seller note can sit on full standby for the entire 10-year loan term under SOP 50 10 8 (effective June 1, 2025). No principal, no interest, until the bank is repaid.
- A strategic buyer can pull COGS levers an MBO team structurally cannot: supplier renegotiation, freight consolidation, landed-cost audits. Modelled at a $5M EBITDA brand, that is roughly $188K of annual EBITDA the MBO team can never reach.
When a DTC (direct-to-consumer) founder under $10M EBITDA (earnings before interest, taxes, depreciation, and amortization) starts thinking about an exit, they usually frame the choice as "strategic buyer vs. private equity." The more common real-world fork is strategic sale vs. management buyout, and the MBO (management buyout) has a structural ceiling most founders do not see until the letter of intent lands on the desk.
The gap is not a negotiating failure. It is baked into who is bidding. A strategic acquirer can pay for value it will create after close. A management team buying the business cannot. This post names the three trade-offs that flip the math, in dollar terms, so you can weigh both paths with your eyes open before you sign anything.
Why financial buyers price differently than strategic buyers
Every buyer values your brand off future cash flow, but they do not all see the same future. A strategic acquirer, usually a larger brand or platform in your category, can underwrite savings and growth you cannot capture alone: shared COGS (cost of goods sold), cross-sell into their customer base, and overhead they can strip out because they already run finance, ops, and logistics. Those combined savings mean the deal is worth more to them than to you standalone, and part of that premium shows up in the price.
A management buyout team is a financial buyer. They are buying the same brand at the same scale, with no platform to fold it into and no shared savings to fund a richer bid. So they price off standalone cash flow and, critically, off a financing structure that has to work for a small equity cheque. That is the whole reason the multiple spread exists. Advisory data is consistent here: strategic buyers pay roughly 1 to 2 turns of EBITDA more than financial buyers for comparable assets, which lands in the 15-30% range on price (Windsor Drake, Website Closers, IB Interview Questions).
When I talk to founders running a brand this size, the thing they keep saying is that the MBO "feels safer" because the buyers are people they trust. That is real. But safe and cheap are not the same thing, and the LOI is where the difference becomes cash.
Trade-off 1: the multiple gap, in dollars, at $5M EBITDA
The abstract spread only matters once you put it in dollars. Take a brand at $5M EBITDA. Financial-buyer bids for $2M+ EBITDA DTC brands ran 4.0x-6.5x in H2 2024; strategic bids ran 5.5x-8.0x when the cost savings were meaningful (Meridian IB, Fall 2024). Size compounds the discount: GF Data's Q3 2025 report puts the overall lower middle market average at 7.5x EBITDA, but deals in the sub-$25M TEV range where a $5M EBITDA brand lands typically come in well below that figure. The TEV-band breakouts in GF Data's subscriber report corroborate a meaningful size discount for smaller deals. A $5M EBITDA brand sits firmly at the bottom of that range.
Model it out. An MBO at 5.0x is a $25M deal, but 15% comes back to you as a seller note, so you walk with about $21.3M in day-one cash. A strategic sale at 5.5x is $27.5M, all cash. That is already a $6.2M swing in what hits your account at closing, and the strategic case only widens from there.
The pattern we see again and again: founders anchor on the headline enterprise value ("both offers are around 5x") and miss that the MBO's headline number is not the number that clears. The seller note is a real haircut on day-one liquidity, and it is the second trade-off.
Returns are quietly eating your margin. See by how much.
Get our Real Cost of Returns calculator: plug in your numbers, see the true hit per return.
Check your inbox. We'll send the Real Cost of Returns calculator shortly.
Trade-off 2: the seller note you become
In an MBO, you almost always become a lender to the buyer. A seller note is part of your price taken as an IOU, paid back over years, instead of cash at close. It is near-universal in MBOs because the management team's equity cheque is small and senior lenders will not fund the entire deal. Across the lower middle market, buyer-type medians for seller notes range from roughly 12% (Corporation buyers) to 18% (Family Office), with Consumer Goods sector deals at about 17% of TEV (Axial, 100-LOI cross-sectional analysis). The broader cross-sectional average sits in the 10-15% range.
Two things about that note matter more than the headline percentage. First, it is subordinated: you are unsecured and last in line behind the bank if the business ever defaults. Second, if the deal uses an SBA 7(a) loan (sometimes used under $5M EBITDA) and your note counts toward the buyer's required equity injection, SBA SOP 50 10 8, effective June 1, 2025, puts that note on full standby for the entire loan term. No principal, no interest, until the bank is repaid, typically 10 years. Operators describe the seller note as "effectively a loan to my employees," and under SBA standby it is a loan with no payments for a decade.
| Rule (SOP 50 10 8, June 2025) | What it means for you as the seller |
|---|---|
| Seller note subordinated to the SBA loan | You are unsecured. The bank gets paid first in any default. |
| Full standby if used for equity injection | No principal or interest until the SBA loan is repaid (typically 10 years). |
| Seller note max 50% of the required equity injection | The buyer can count your note for at most about 5% of deal price as "equity." |
| SBA Form 155 standby agreement required | You sign a document saying you cannot sue for payment while the SBA loan is outstanding. |
| Seller note must mature after the SBA loan | Your payoff date is pushed beyond the bank's 10-year term. |
A conventional (non-SBA) seller note is gentler: 5-25% of price, 3-7 year term, 5-8% interest, still subordinated (Morgan & Westfield). The point is not that seller notes are always bad. It is that "5x" in an MBO with a standby note is a very different number than "5x" all cash, and you have to know which one you are being offered before you negotiate the multiple.
Trade-off 3: the COGS they can't reach without your scale
The third gap is the one founders underrate most, because it is invisible on the term sheet. A strategic buyer folds your brand into an existing platform and immediately gains procurement pricing power you never had. Procurement savings typically run 5-15% of combined COGS (CT Acquisitions): renegotiating supplier pricing at higher combined volume, consolidating inbound freight into full containers instead of partial ones, and running a landed-cost audit on duties and tariffs. Each of those points drops straight into gross margin, so the effect on the contribution margin that ultimately drives your valuation is direct.
Model those levers at a $5M EBITDA brand (roughly $20M revenue). Supplier renegotiation on your top SKUs at double the minimum order quantity is worth about $75K of annual EBITDA. Freight consolidation adds roughly $50K. A volume-tiered pricing move adds about $37K, and a landed-cost audit another $25K. That is close to $188K of annual EBITDA, every year, that the strategic buyer can capture and the MBO team structurally cannot, because the MBO team is buying your brand at exactly today's scale.
This is why the multiple gap is structural, not a haggling artifact. The strategic buyer is not being generous. They can underwrite a higher price because they can pull levers that convert into margin the day after close. When we've helped founders pressure-test both offers, the moment it clicks is when they see that the strategic buyer's "extra" turn of EBITDA is partly funded by savings the MBO team can never touch. These figures are a modelled estimate, not a reported deal outcome, but the direction is not in doubt: scale buys procurement pricing power, and an MBO adds no scale.
When an MBO can still make sense (and when it can't)
None of this makes an MBO the wrong answer. It makes it a priced answer. There are real cases where the trade is worth it: a founder-brand whose identity a strategic integration would flatten, where keeping the team preserves the equity; a situation where speed and privacy matter and you do not want a banker shopping your numbers through an information memorandum; or simply a market where no credible strategic bidder exists. In those cases you are trading price for certainty, continuity, and control of the story, and that can be a rational trade.
What you cannot do is make that trade blind. The most expensive mistake we see is a founder accepting an MBO because it "feels right" without ever modelling the strategic alternative, so they never learn the gap was $5M. Put both paths in a spreadsheet first, then decide what continuity is worth to you.
| Factor | Management buyout (MBO) | Strategic sale |
|---|---|---|
| Typical EBITDA multiple (DTC $3-10M EBITDA) | 4.0x-5.5x | 5.5x-8.0x |
| Day-one cash at $5M EBITDA, 5x bid | About $21M (after seller note) | $25M-$32M |
| Seller note required? | Almost always (5-25% of deal) | Rare |
| Seller note standby risk | High (SBA: full 10-yr standby possible) | Not applicable |
| Competitive bidding process? | No, bilateral negotiation | Yes, banker runs an auction |
| COGS savings upside for buyer? | No, same scale as today | Yes, 2-5 gross margin points possible |
| Time to close | Faster (3-5 months typical) | Longer (6-12 months with a banker) |
| Integration disruption risk | Low, same team | Moderate to high |
The MBO is not the safe choice. It is the choice that trades day-one dollars for continuity and control. Sometimes that trade is worth it. But you can only make it well if you have priced the strategic alternative in the same spreadsheet, note terms and all, before you sign the letter of intent.
How to run the comparison before you sign anything
Here is the sequence that keeps founders honest. Get a third-party valuation before you talk multiples with anyone, so you have an anchor that is not the buyer's. Run both scenarios in one deal model: strategic all-cash on one side, MBO deal value minus the seller note on the other, and do not net the note back at face value if it is on standby, because a dollar you collect in year 10 with no interest is not worth a dollar today. Read your note terms (subordination, standby, maturity, interest) before you agree to a headline multiple, because the terms are where the MBO's real cost hides. And confirm whether the management team is even pre-approved for SBA or conventional financing, since that determines the standby rules you would be living with.
Operators at this stage tell us the single most clarifying exercise is writing the two day-one cash numbers side by side on one line. Strategic $27.5M. MBO $21.3M in hand plus a $3.8M note you might not touch for a decade. When the gap is a number instead of a feeling, the decision gets a lot easier, whichever way you go. Building that side-by-side before you sign is exactly what our interim CFO team does on a sell-side mandate.
Sources and methodology
Lower middle market EBITDA multiples are drawn from GF Data's Q3 2025 report. GF Data's Q3 2025 free summary puts the overall lower middle market average at 7.5x EBITDA for Q3 2025 (up from 6.9x in Q2). TEV-band breakouts showing the size discount for sub-$25M deals are available in GF Data's subscriber report and are corroborated directionally by advisory sources cited here. GF Data tracks PE-sponsored deals; the strategic-versus-financial split and the exact TEV-band figures are not available from the free release. See the GF Data Q3 2025 summary.
DTC buyer-type multiple ranges come from a dated ecommerce M&A market update. Meridian IB's Fall 2024 DTC Ecommerce M&A Market Update reports financial-buyer add-on bids of 4.0x-6.5x for $2M+ EBITDA brands and higher strategic ranges when cost savings are present. See the Meridian IB Fall 2024 update.
The strategic-over-financial premium is an advisory consensus, stated as a range. Multiple M&A advisory publishers put the strategic premium at roughly 1-2 turns of EBITDA, or 15-30% on price, versus financial buyers. This is a consensus range, not a single reported dataset. See Windsor Drake and Website Closers.
Seller-note prevalence is from a 100-LOI analysis of lower middle market deals. The Axial analysis of 100 letters of intent finds seller notes across buyer types and sectors, with buyer-type medians running from roughly 11.7% (Corporation) to 18.2% (Family Office), and industry medians from roughly 11.7% (Healthcare) to 21.0% (Technology), with Consumer Goods at 16.7%. The analysis does not publish a year-over-year time series; the 10-15% figure cited in this post reflects the cross-sectional range for lower middle market deals. All figures are medians expressed as a percentage of TEV. The data is cross-sector, not DTC-specific. See the Axial seller-note analysis.
SBA standby rules are from SOP 50 10 8, effective June 1, 2025. When a seller note is used toward the buyer's required equity injection on an SBA 7(a) loan, it must be on full standby for the loan term and capped at 50% of the injection, formalized via an SBA Form 155 standby agreement. See the Whiteford client alert on SOP 50 10 8.
COGS savings figures are a modelled estimate, not a reported deal outcome. Procurement savings of 5-15% of combined COGS are drawn from supply-chain M&A guidance; the per-lever EBITDA uplift is modelled on a roughly $20M revenue, $5M EBITDA brand and marked as an estimate. See CT Acquisitions on supply-chain cost savings.
Frequently asked questions
what's the difference between a strategic buyer and a management buyout in how much they pay?
A strategic buyer can underwrite cost savings and growth (shared COGS, cross-sell, removed overhead) and pay for value they will create after close. A management buyout team is a financial buyer with none of that, so they bid off standalone cash flow. That usually leaves a 15-30% gap, or roughly 1-2 turns of EBITDA, in the strategic buyer's favor.
why does an mbo buyer usually offer a lower multiple than a strategic acquirer?
Two reasons. First, no cost-savings budget: the team is buying the same brand at the same scale, so there is no shared logistics or procurement upside to fund a higher price. Second, no auction: an MBO is a bilateral negotiation, not a competitive process, and the management team's job is to bid low. Both forces push the multiple down.
what is a seller note and why do mbo deals almost always have one?
A seller note is financing you provide to the buyer: you take part of your price as an IOU paid over several years instead of cash at closing. MBO teams almost always need one because their own equity cheque is small and lenders will not fund the whole deal. In effect you are lending the buyer part of your own purchase price.
what does the sba 7a standby provision mean for the seller note i'd be holding?
If the buyer uses an SBA 7(a) loan and applies your seller note toward the required equity injection, SOP 50 10 8 (effective June 1, 2025) puts that note on full standby for the entire loan term, typically 10 years. That means no principal and no interest to you until the bank is fully repaid, and you sign an SBA standby agreement saying you cannot sue for payment in the meantime.
how long could i wait to receive the seller note portion of my mbo proceeds?
It depends on the structure. A conventional (non-SBA) seller note usually matures in 3-7 years at 5-8% interest. An SBA-financed note used for equity injection can be on standby for the full 10-year loan term, so you may collect nothing on that slice until year 10. Always confirm the standby terms before you agree to a multiple.
what supply chain savings can a strategic buyer reach that an mbo buyer can't?
Procurement savings typically run 5-15% of combined COGS: renegotiating supplier pricing at higher volume, consolidating inbound freight into full containers, and auditing landed cost and duties. A strategic buyer with an existing platform has the scale to negotiate those. An MBO team is buying your brand at exactly today's scale, so their pricing power with suppliers is unchanged.
is there any scenario where an mbo makes more sense than a strategic sale?
Yes. If continuity matters (a founder-brand where the team preserves the identity a strategic integration would flatten), if speed and privacy matter (no banker process, no information memorandum shopping your numbers), or if no credible strategic bidder exists, an MBO can be the right call. You are trading price for certainty and control of the story. Just price that trade in dollars first.
what's a realistic seller note percentage in a dtc brand mbo under $10m ebitda?
Plan for 5-25% of the purchase price. Cross-sectional data from lower middle market LOI analysis puts consumer-sector deals in the 10-17% range; the broader average sits around 10-15%. In a smaller MBO where the team's equity is thin, expect the higher end. The exact figure depends on how much senior debt the deal supports and whether it is SBA or conventional financing.